<DOC>
	<DOCNO>NCT02277886</DOCNO>
	<brief_summary>Among patient experience GERD symptom , 89 % report nocturnal symptom , result poor sleep quality . Sodium alginate oral suspension ( Alginos ) medication indicated relief gastroesophageal reflux symptom . This multi-center , open-label , randomized trial intend compare addition one dose Alginos ( 50mg/ml , 20ml ) bed time ( Nexium plus Alginos ) , additional alginate treatment ( Nexium alone ) , erosive GERD patient take Nexium ( 40mg/tablet ) daily 4 week . Efficacy endpoint include percentage patient relief complete resolution nighttime heartburn ( regurgitation ) , percentage patient relief complete resolution GERD-related sleep disturbance , percentage night without nighttime heartburn ( regurgitation ) treatment period , change baseline Pittsburgh Sleep Quality Index ( PSQI ) questionnaire total score , change percentage patient relief nighttime heartburn ( regurgitation ) post-treatment visit compare final visit test group ( Nexium plus Alginos ) . Safety endpoint incidence adverse event . The study hypothesis sodium alginate plus esomeprazole superior esomeprazole alone relieve nighttime reflux symptom sleep disturbance erosive GERD patient .</brief_summary>
	<brief_title>Esomeprazole Plus Alginate vs. Esomeprazole Alone Treatment Nighttime Reflux Symptom Sleep Disturbances</brief_title>
	<detailed_description>This multi-center , open-label , randomized trial aim compare efficacy safety profile sodium alginate oral suspension ( 50mg/ml ) 20ml bedtime esomeprazole ( 40mg/tablet ) 1 tablet daily treatment erosive GERD patient Taiwan . Patients enrol study diagnose GERD ( grade A~D ) ; history heartburn ( regurgitation ) ≥ 3 month enter study ; history GERD-related sleep disturbance ≥ 1 month enter study ; nighttime heartburn ( regurgitation ) grade moderate , severe , ≥ 3 night last 7 day screen period ; GERD-related sleep disturbance ≥ 3 night last 7 day screen period ; global PSQI score &gt; 5 ; sign informed consent . Patients exclude diagnosed non-erosive GERD , Barrett 's esophagus esophageal stricture ; condition GERD could primary cause sleep disturbance ; active esophageal , gastric duodenal ulcer ; history esophageal , gastric duodenal surgery ; active cancer kind ; female patient pregnant lactating ; allergy study drug ; take proton pump inhibitor ( PPI ) within 7 day , prokinetic agent , H2-blocker , alginate preparation antacid within 2 day screen ; history drug addiction alcohol abuse within past 12 month ; condition diseases investigator considers appropriate enter study . The primary efficacy endpoint percentage patient relief nighttime heartburn ( acid regurgitation ) . The secondary efficacy endpoint percentage patient complete resolution nighttime heartburn ( regurgitation ) ; percentage patient relief GERD-related sleep disturbance ; percentage patient complete resolution GERD-related sleep disturbance ; percentage night without nighttime heartburn ( regurgitation ) treatment period ; change baseline Pittsburgh Sleep Quality Index questionnaire total score ( global PSQI score ) end study ; change percentage patient relief nighttime heartburn ( acid regurgitation ) post-treatment visit ( V4 ) compare final visit ( V3 ) test group ( Nexium plus Alginos ) . The safety endpoint incidence adverse event . This study aim prove sodium alginate plus esomeprazole superior esomeprazole alone relieve nighttime reflux symptom sleep disturbance erosive GERD patient .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Heartburn</mesh_term>
	<mesh_term>Dyssomnias</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Alginic acid</mesh_term>
	<criteria>Out patient age 2080 year old ( inclusive ) Taiwan gender Patients previously diagnose erosive GERD ( i.e . grade A~D accord modify LosAngeles Classification . Endoscopic examination result within 21 day randomization visit ( V2 ) acceptable . Patients history heartburn ( regurgitation ) ≥ 3 month enter study Patients history GERDrelated sleep disturbance ≥ 1 month enter study Patients nighttime heartburn ( regurgitation ) grade moderate , severe , ≥ 3 night last 7 day screen period Patients GERDrelated sleep disturbance ≥ 3 night last 7 day screen period Patients global PSQI score &gt; 5 Patients sign informed consent form Patients nonerosive GERD , Barrett 's esophagus esophageal stricture Patients condition GERD could primary cause sleep disturbance ( e.g . sleep apnoea , obstruct airway , severe depression , severe anxiety , panic attack , chronic obstructive pulmonary disease require oxygen therapy ) Patients active esophageal , gastric duodenal ulcer Patients history esophageal , gastric duodenal surgery Patients active cancer kind Female patient pregnant lactate Patients allergy study drug Patients take proton pump inhibitor ( PPI ) within 7 day , prokinetic agent , H2blocker , alginate preparation antacid within 2 day screen Patients history drug addiction alcohol abuse within past 12 month Patients condition disease investigator considers appropriate enter study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>sodium alginate</keyword>
	<keyword>esomeprazole</keyword>
	<keyword>GERD</keyword>
</DOC>